HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
We, the undersigned, commend you for your leadership and commitment to reducing out-of-control prescription drug prices and stopping anti-competitive abuses that keep drug prices high. We are encouraged that the Senate Judiciary Committee has noticed a markup of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974). We thank you for your efforts to move this important piece of legislation through the Committee.
Related Posts
HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Announces Healthcare Cybersecurity Key Considerations
The Healthcare Supply Chain Association (HSCA) today announced the release of key...
HSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
Washington, DC (August 21, 2018) – The Healthcare Supply Chain Association...
HSCA Applauds Senate Judiciary Committee for Advancing the CREATES Act
Washington, DC (June 14, 2018) – Healthcare Supply Chain Association (HSCA)...